ASSETMARK, INC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
ASSETMARK, INC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$787,895
-6.2%
28,578
+2.3%
0.00%0.0%
Q2 2023$840,147
-10.8%
27,949
+7.5%
0.00%
-25.0%
Q1 2023$941,726
+7.5%
25,993
+5.8%
0.00%0.0%
Q4 2022$876,412
+7.8%
24,570
+2.3%
0.00%0.0%
Q3 2022$813,000
+1378.2%
24,012
+1160.5%
0.00%
Q2 2022$55,000
+5.8%
1,905
+17.4%
0.00%
Q1 2022$52,000
+8.3%
1,622
-0.9%
0.00%
Q4 2021$48,000
+14.3%
1,637
+3.3%
0.00%
Q3 2021$42,000
-12.5%
1,584
+1.0%
0.00%
Q2 2021$48,000
+17.1%
1,569
-0.2%
0.00%
Q1 2021$41,000
+7.9%
1,572
+5.4%
0.00%
Q4 2020$38,000
+35.7%
1,491
+12.1%
0.00%
Q3 2020$28,000
+27.3%
1,330
+46.2%
0.00%
Q2 2020$22,000
+2100.0%
910
+1321.9%
0.00%
Q1 2020$1,000
-50.0%
64
-25.6%
0.00%
Q4 2019$2,0000.0%86
+10.3%
0.00%
Q3 2019$2,000
+100.0%
78
+358.8%
0.00%
Q4 2017$1,000170.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders